Groneck P - Search Results

1

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, Burdach S. Dirksen U, et al. Among authors: groneck p. J Clin Invest. 1997 Nov 1;100(9):2211-7. doi: 10.1172/JCI119758. J Clin Invest. 1997. PMID: 9410898 Free PMC article.

2

Pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia.

Groneck P, Speer CP. Groneck P, et al. Pediatr Pulmonol Suppl. 1997;16:29-30. doi: 10.1002/ppul.1950230816. Pediatr Pulmonol Suppl. 1997. PMID: 9443185 Review. No abstract available.

3

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study.

Möller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L, Reiss I, Kohl M, Demirakca S, Hentschel R, Paul T, Vierzig A, Groneck P, von Seefeld H, Schumacher H, Gortner L; Surfactant ARDS Study Group. Möller JC, et al. Among authors: groneck p. Intensive Care Med. 2003 Mar;29(3):437-46. doi: 10.1007/s00134-003-1650-1. Epub 2003 Feb 15. Intensive Care Med. 2003. PMID: 12589529 Free PMC article. Clinical Trial.

4

Decreased expression of angiogenic factors in placentas with chorioamnionitis after preterm birth.

Kramer BW, Kaemmerer U, Kapp M, Herbst D, Marx A, Berg D, Groneck PA, Speer CP. Kramer BW, et al. Among authors: groneck pa. Pediatr Res. 2005 Sep;58(3):607-12. doi: 10.1203/01.PDR.0000175641.39056.7A. Pediatr Res. 2005. PMID: 16148081

5

Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus.

Felderhoff-Mueser U, Buhrer C, Groneck P, Obladen M, Bartmann P, Heep A. Felderhoff-Mueser U, et al. Among authors: groneck p. Pediatr Res. 2003 Nov;54(5):659-64. doi: 10.1203/01.PDR.0000084114.83724.65. Epub 2003 Jul 16. Pediatr Res. 2003. PMID: 12867600

6

Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment.

Groneck P, Oppermann M, Speer CP. Groneck P, et al. Pediatr Res. 1993 Nov;34(5):586-90. doi: 10.1203/00006450-199311000-00006. Pediatr Res. 1993. PMID: 8284093 Clinical Trial.

7

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease.

Groneck P, Reuss D, Götze-Speer B, Speer CP. Groneck P, et al. J Pediatr. 1993 Jun;122(6):938-44. doi: 10.1016/s0022-3476(09)90024-5. J Pediatr. 1993. PMID: 8388949 Clinical Trial.

8

Inflammatory mediators and bronchopulmonary dysplasia.

Groneck P, Speer CP. Groneck P, et al. Arch Dis Child Fetal Neonatal Ed. 1995 Jul;73(1):F1-3. doi: 10.1136/fn.73.1.f1. Arch Dis Child Fetal Neonatal Ed. 1995. PMID: 7552588 Free PMC article. No abstract available.

9

Multiple hepatic mesenchymal hamartomas in a premature associated with placental mesenchymal dysplasia.

Mack-Detlefsen B, Boemers TM, Groneck P, Bald R. Mack-Detlefsen B, et al. Among authors: groneck p. J Pediatr Surg. 2011 Aug;46(8):e23-5. doi: 10.1016/j.jpedsurg.2011.04.094. J Pediatr Surg. 2011. PMID: 21843704

10

Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn.

Soditt V, Aring C, Groneck P. Soditt V, et al. Among authors: groneck p. Intensive Care Med. 1997 Dec;23(12):1275-8. doi: 10.1007/s001340050498. Intensive Care Med. 1997. PMID: 9470085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results